Literature DB >> 15802963

HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages.

Laura Gillim-Ross1, Andrea Cara, Mary E Klotman.   

Abstract

HIV-1 extrachromosomal 2-LTR circles (cc2LTR) are rapidly lost in dividing cell populations and, therefore, might be interpreted as representing new infection and ongoing viral replication. However, recent work demonstrated that cc2LTR persist in infected, growth-arrested T cell lines beyond their predicted half-life as previously determined in dividing cell populations. In this study, the evaluation of the stability of cc2LTR was extended to include primary human macrophages, a natural, non-dividing target of HIV-1. By quantitative real-time PCR, cc2LTR were found to persist out to 21 days post-infection in macrophages infected with both integrase competent and integrase- defective, recombinant HIV-1, whereas in activated CD4(+) T lymphocytes, they rapidly decreased over time. This persistence was associated with persistent, low level expression of the indicator gene, luciferase. These data suggest that the presence of HIV-1 cc2LTR in the PBMC of HIV-1-infected patients on suppressive HAART could be due either to ongoing generation of newly infected dividing cells, or persistence of circles in non-dividing cell populations where they appear to be stable. Furthermore, exrachromosomal circular DNA in this cell population could be a source of persisent viral protein expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802963     DOI: 10.1089/vim.2005.18.190

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  42 in total

Review 1.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap.

Authors:  David J Garfinkel; Karen M Stefanisko; Katherine M Nyswaner; Sharon P Moore; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

3.  Persistent transcription of a nonintegrating mutant of simian immunodeficiency virus in rhesus macrophages.

Authors:  Yanfang Zheng; Ilnour Ourmanov; Vanessa M Hirsch
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

Review 4.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

5.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 6.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

7.  Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells.

Authors:  Donatella R M Negri; Roberta Bona; Zuleika Michelini; Pasqualina Leone; Iole Macchia; Mary E Klotman; Mirella Salvatore; Andrea Cara
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

8.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

9.  HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells.

Authors:  Matthew J Pace; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2013-03-26       Impact factor: 3.616

Review 10.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.